• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

IVI Research Brief Uses Insurance Value to Determine Long-Term Value of Therapies

Article

A research brief from the Innovation and Value Initiative (IVI) looked at how the concept of insurance value can help stakeholders understand the value of therapies to the broader population.

A research brief from the Innovation and Value Initiative (IVI) looked at how the concept of insurance value can help stakeholders understand the value of therapies to the broader population. Insurance value measures the value that medical technologies offer healthy individuals by reducing the physical risks of possible illness, and the concept has been suggested as one of several elements to improve and enhance conventional cost-effecteness analysis.

The brief used IVI's Open-Source Value Platform mofel for rheumatoid arthritis (RA) to explore the application of insurance value because treatent of RA focuses on reducing impacts on quality of life rather than addressing mortality concerns.

Read the full research brief.

Related Videos
Michael David Chuong, MD, radiation oncologist, Miami Cancer Institute, Baptist Health South Florida
Yuman Fong, MD, cancer surgeon, City of Hope
Enrique Velazquez Villarreal, MD, PhD, MPH, MS, assistant professor in the department of integrative translational sciences at City of Hope
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Dr Debra Patt
Ira Zackon, MD, senior medical director, Ontada
Danielle Roman, PharmD, BCOP, Allegheny Health Network
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.